File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Angioplasty and primary stenting of high-grade, long-segment superficial femoral artery disease: Is it worthwhile?

TitleAngioplasty and primary stenting of high-grade, long-segment superficial femoral artery disease: Is it worthwhile?
Authors
Issue Date2003
PublisherElsevier Inc.
Citation
Annals Of Vascular Surgery, 2003, v. 17 n. 4, p. 430-437 How to Cite?
AbstractThe purpose of this study was to determine the long-term results and efficacy of angioplasty and stenting of long-segment, high-grade superficial femoral artery disease. Seventy-three consecutive primary balloon angioplasty procedures with immediate stenting in 70 patients with SVS/ISCVS grade B2 or C superficial femoral artery (SFA) disease exceeding 5 cm in length were evaluated. The mean lesion length was 16 cm and occlusion constituted 62%, with a runoff score of 8. Forty-nine procedures (67%) were performed for critical ischemia. A total of 135 stents were placed. Follow-up was with 3-month duplex ultrasound; stenosis >50% was considered the end point for failure. Mean follow-up time was 26 months. Initial technical success with intent to treat was 90%. Initial success according to anatomic, hemodynamic, and clinical criteria was 90%, 88%, and 88%, respectively, with intent to treat. Limb salvage in the critical ischemia group was 71%. Overall cumulative primary patency rates at 12, 24, and 48 months were 56%, 35%, and 22%, and secondary patency rates were 69%, 47%, and 37%, respectively. A stented segment length >10 cm and procedure in claudicants incurred an inferior patency rate. Treatment of high-grade SFA lesions with angioplasty and primary setting results in lower long-term patency rate than those with surgery, but combined with secondary interventions this treatment option may be an acceptable alternative in selected patients with critical ischemia. Femoropopliteal bypass remains the procedure of choice.
Persistent Identifierhttp://hdl.handle.net/10722/84151
ISSN
2015 Impact Factor: 1.045
2015 SCImago Journal Rankings: 0.586
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorCheng, SWKen_HK
dc.contributor.authorTing, ACWen_HK
dc.contributor.authorHo, Pen_HK
dc.date.accessioned2010-09-06T08:49:33Z-
dc.date.available2010-09-06T08:49:33Z-
dc.date.issued2003en_HK
dc.identifier.citationAnnals Of Vascular Surgery, 2003, v. 17 n. 4, p. 430-437en_HK
dc.identifier.issn0890-5096en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84151-
dc.description.abstractThe purpose of this study was to determine the long-term results and efficacy of angioplasty and stenting of long-segment, high-grade superficial femoral artery disease. Seventy-three consecutive primary balloon angioplasty procedures with immediate stenting in 70 patients with SVS/ISCVS grade B2 or C superficial femoral artery (SFA) disease exceeding 5 cm in length were evaluated. The mean lesion length was 16 cm and occlusion constituted 62%, with a runoff score of 8. Forty-nine procedures (67%) were performed for critical ischemia. A total of 135 stents were placed. Follow-up was with 3-month duplex ultrasound; stenosis >50% was considered the end point for failure. Mean follow-up time was 26 months. Initial technical success with intent to treat was 90%. Initial success according to anatomic, hemodynamic, and clinical criteria was 90%, 88%, and 88%, respectively, with intent to treat. Limb salvage in the critical ischemia group was 71%. Overall cumulative primary patency rates at 12, 24, and 48 months were 56%, 35%, and 22%, and secondary patency rates were 69%, 47%, and 37%, respectively. A stented segment length >10 cm and procedure in claudicants incurred an inferior patency rate. Treatment of high-grade SFA lesions with angioplasty and primary setting results in lower long-term patency rate than those with surgery, but combined with secondary interventions this treatment option may be an acceptable alternative in selected patients with critical ischemia. Femoropopliteal bypass remains the procedure of choice.en_HK
dc.languageengen_HK
dc.publisherElsevier Inc.en_HK
dc.relation.ispartofAnnals of Vascular Surgeryen_HK
dc.rightsAnnals of Vascular Surgery. Copyright © Elsevier Inc.en_HK
dc.subject.meshAgeden_HK
dc.subject.meshAngioplasty, Balloonen_HK
dc.subject.meshArterial Occlusive Diseases - therapyen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshFemoral Arteryen_HK
dc.subject.meshFollow-Up Studiesen_HK
dc.subject.meshHumansen_HK
dc.subject.meshIntermittent Claudication - therapyen_HK
dc.subject.meshIschemia - therapyen_HK
dc.subject.meshLeg - blood supplyen_HK
dc.subject.meshMaleen_HK
dc.subject.meshProspective Studiesen_HK
dc.subject.meshStentsen_HK
dc.subject.meshTime Factorsen_HK
dc.subject.meshVascular Patencyen_HK
dc.titleAngioplasty and primary stenting of high-grade, long-segment superficial femoral artery disease: Is it worthwhile?en_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0890-5096&volume=17&issue=4&spage=430&epage=437&date=2003&atitle=Angioplasty+and+primary+stenting+of+high-grade,+long-segment+superficial+femoral+artery+disease:+is+it+worthwhile?en_HK
dc.identifier.emailCheng, SWK: wkcheng@hkucc.hku.hken_HK
dc.identifier.authorityCheng, SWK=rp00374en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s10016-003-0028-8en_HK
dc.identifier.pmid14670023-
dc.identifier.scopuseid_2-s2.0-0141780928en_HK
dc.identifier.hkuros87759en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0141780928&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume17en_HK
dc.identifier.issue4en_HK
dc.identifier.spage430en_HK
dc.identifier.epage437en_HK
dc.identifier.isiWOS:000185650300012-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridCheng, SWK=7404684779en_HK
dc.identifier.scopusauthoridTing, ACW=7102858552en_HK
dc.identifier.scopusauthoridHo, P=24469553100en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats